AI assistant
Adaptive Biotechnologies Corp — Director's Dealing 2024
Mar 7, 2024
31660_dirs_2024-03-06_1f574c02-0552-4a49-a98c-e8da04d3ff3c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2024-03-04
Reporting Person: BENZENO SHARON (Chief Commercial Ofc Imm Med)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-04 | Common Stock | A | 132979 | — | Acquired | 356805 | Direct |
| 2024-03-05 | Common Stock | S | 10746 | $3.43 | Disposed | 346059 | Direct |
| 2024-03-05 | Common Stock | S | 18644 | $3.44 | Disposed | 327415 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | Stock Option (right to buy) | $3.99 | A | 199549 | Acquired | 2034-03-04 | Common Stock (199549) | Direct |
Footnotes
F1: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2: The options vest with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.